Symbol not found

:ALBO 00:00AM GMT

0.00

0.00 (0.00%)

Market Cap (Intraday)	NA
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$13.8 Million
Adjusted EPS	-$1.83

See more estimates

10-Day MA	N/A
50-Day MA	N/A
200-Day MA	N/A

See more pivots

Albireo Pharma Inc Stock, :ALBO

53 State Street, 19th Floor, Boston, Massachusetts 02109

United States of America

Phone: +1.857.254.5555

Number of Employees:

http://www.albireopharma.com

Description

Albireo Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Its pipeline products include Odevixibat, A3384, and Elobixibat. The company was founded by Jan Peter Mattsson and Per-GÃ?Â¶ran Gillberg on December 8, 2003 and is headquartered in Boston, MA.